In case 1, the patient had normal liver function and tumor marker, AFP and PIVKA-II were within the normal ranges which can be considered to be low risk for HCC except for a dynamic CT study showing a tumor with an HCC-like enhancement pattern. This evidence concerns the gene AFP and hepatocellular carcinoma.